<DOC>
	<DOCNO>NCT03104283</DOCNO>
	<brief_summary>The purpose study assess efficacy safety apatinib elderly advanced gastric cancer patient , find relationship expression VEGFR-2 efficacy apatinib treatment .</brief_summary>
	<brief_title>Apatinib Elderly Advanced Gastric Cancer</brief_title>
	<detailed_description>The trial fund Chinese Society Clinical Oncology-Beijing Xisike Clinical Oncology Research Fundation . The trial prepare registered clinicaltrail.gov . Quality assurance plan : Every participant enrol exclude two practiced investigator . And two investigator participate step trail , include record data , compare investigator . If data consistent , investigator would record data ; , data would check decide two investigator . All step data site monitor audited staff research financial department Affliated Hospital Qinghai University . Data check : The investigator compare data enter registry predefined rule range consistency data field registry . Source data verification : The investigator assess accuracy , completeness , representativeness registry data compare data external data source , include medical record electronic case report form . Data dictionary contains detailed description variable used registry , include source variable , cod information , normal range relevant . Standard Operating Procedures address registry operation analysis activity , participant recruitment , data collection , data management , data analysis , report adverse event , change management . All registry operation would do accord specific step , two practice investigator . Sample size assessment specify number participant participant year necessary demonstrate effect . According formula differ advantage disadvantage , investigator need least 60 participant take part trail . The investigator recruit 20 participant every year accord previous experience , investigator recruit least three year . Plan miss data : The investigator would collect much data possible , investigator exclude participant cooperate recruitment . And investigator manage situation accord statistical principle variable report miss , unavailable , non-reported , uninterpretable , consider miss data inconsistency out-of-range result . Statistical analysis plan : Statistical analysis would perform use SPSS software , version 13.0 ( SPSS Inc. , IL , USA ) . Survival analysis would perform use Kaplan-Meier methodology . Fisher 's exact test would use analyze efficacy treatment . Cox proportional hazard model would use multivariate analysis . The level significance define P &lt; 0.05 .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>1 . Elderly patient ( age ≥ 60 year ) histologically confirm advanced adenocarcinoma stomach gastroesophageal junction ; 2 . Eastern Cooperative Oncology Group ( ECOG ) performance status 01 ; 3 . Progression intolerance one line chemotherapy ; 4 . At least one measurable lesion define RECIST 1.1 ; 5 . With acceptable hematologic , cardiac , hepatic , pulmonary renal function ; 6 . Can take apatinib orally ; 7 . Estimated life expectancy ≥ 3 month . 1 . Patients take apatinib orally reason ; 2 . Patients uncontrolled central nervous system ( CNS ) metastases ; 3 . Patients massive hydrothorax ascites ; 4 . Proteinuria 2+ 24hour urinary protein ≥ 1g ; 5 . Newlyhappened traumatism pathological fracture ; 6 . Estimated life expectancy ˂ 3 month ; 7 . Received chemotherapy past 28 day enrollment ; 8 . Patients uncontrolled blood pressure medication ( ≥ 140/90 mmHg ) ; 9 . Patients bleed tendency , receive thrombolytic anticoagulant , receive intravenous antibiotic treatment , receive bevacizumab VEGF TKIs , primary malignancy ( except basal cell skin cancer cervical carcinoma situ ) .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>apatinib</keyword>
	<keyword>gastric cancer</keyword>
	<keyword>elderly patient</keyword>
</DOC>